303 related articles for article (PubMed ID: 32457351)
1. CCL3-CCR5 axis contributes to progression of esophageal squamous cell carcinoma by promoting cell migration and invasion via Akt and ERK pathways.
Kodama T; Koma YI; Arai N; Kido A; Urakawa N; Nishio M; Shigeoka M; Yokozaki H
Lab Invest; 2020 Sep; 100(9):1140-1157. PubMed ID: 32457351
[TBL] [Abstract][Full Text] [Related]
2. Cyr61 promotes CD204 expression and the migration of macrophages via MEK/ERK pathway in esophageal squamous cell carcinoma.
Shigeoka M; Urakawa N; Nishio M; Takase N; Utsunomiya S; Akiyama H; Kakeji Y; Komori T; Koma Y; Yokozaki H
Cancer Med; 2015 Mar; 4(3):437-46. PubMed ID: 25620088
[TBL] [Abstract][Full Text] [Related]
3. GDF15 derived from both tumor-associated macrophages and esophageal squamous cell carcinomas contributes to tumor progression via Akt and Erk pathways.
Urakawa N; Utsunomiya S; Nishio M; Shigeoka M; Takase N; Arai N; Kakeji Y; Koma Y; Yokozaki H
Lab Invest; 2015 May; 95(5):491-503. PubMed ID: 25730371
[TBL] [Abstract][Full Text] [Related]
4. CCL3-CCR5 axis promotes cell migration and invasion of colon adenocarcinoma via Akt signaling pathway.
Guan B; Li H; Yao J; Guo J; Yu F; Li G; Wan B; Ma J; Huang D; Sun L; Chen Y
Environ Toxicol; 2023 Jan; 38(1):172-184. PubMed ID: 36346222
[TBL] [Abstract][Full Text] [Related]
5. Chemokine (C-C Motif) Ligand 1 Derived from Tumor-Associated Macrophages Contributes to Esophageal Squamous Cell Carcinoma Progression via CCR8-Mediated Akt/Proline-Rich Akt Substrate of 40 kDa/Mammalian Target of Rapamycin Pathway.
Fujikawa M; Koma YI; Hosono M; Urakawa N; Tanigawa K; Shimizu M; Kodama T; Sakamoto H; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
Am J Pathol; 2021 Apr; 191(4):686-703. PubMed ID: 33460563
[TBL] [Abstract][Full Text] [Related]
6. CXCL8 derived from tumor-associated macrophages and esophageal squamous cell carcinomas contributes to tumor progression by promoting migration and invasion of cancer cells.
Hosono M; Koma YI; Takase N; Urakawa N; Higashino N; Suemune K; Kodaira H; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
Oncotarget; 2017 Dec; 8(62):106071-106088. PubMed ID: 29285315
[TBL] [Abstract][Full Text] [Related]
7. NCAM- and FGF-2-mediated FGFR1 signaling in the tumor microenvironment of esophageal cancer regulates the survival and migration of tumor-associated macrophages and cancer cells.
Takase N; Koma Y; Urakawa N; Nishio M; Arai N; Akiyama H; Shigeoka M; Kakeji Y; Yokozaki H
Cancer Lett; 2016 Sep; 380(1):47-58. PubMed ID: 27317650
[TBL] [Abstract][Full Text] [Related]
8. Urokinase plasminogen activator secreted by cancer-associated fibroblasts induces tumor progression via PI3K/AKT and ERK signaling in esophageal squamous cell carcinoma.
Tian B; Chen X; Zhang H; Li X; Wang J; Han W; Zhang LY; Fu L; Li Y; Nie C; Zhao Y; Tan X; Wang H; Guan XY; Hong A
Oncotarget; 2017 Jun; 8(26):42300-42313. PubMed ID: 28404945
[TBL] [Abstract][Full Text] [Related]
9. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
[TBL] [Abstract][Full Text] [Related]
10. Astrocyte elevated gene-1 regulates CCL3/CCR5-induced epithelial-to-mesenchymal transition via Erk1/2 and Akt signaling in cardiac myxoma.
Shi P; Fang C; Pang X
Oncol Rep; 2015 Sep; 34(3):1319-26. PubMed ID: 26134542
[TBL] [Abstract][Full Text] [Related]
11. ANXA10 induction by interaction with tumor-associated macrophages promotes the growth of esophageal squamous cell carcinoma.
Kodaira H; Koma YI; Hosono M; Higashino N; Suemune K; Nishio M; Shigeoka M; Yokozaki H
Pathol Int; 2019 Mar; 69(3):135-147. PubMed ID: 30758105
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of MicroRNA-644a Promotes Esophageal Squamous Cell Carcinoma Aggressiveness and Stem Cell-like Phenotype via Dysregulation of PITX2.
Zhang JX; Chen ZH; Xu Y; Chen JW; Weng HW; Yun M; Zheng ZS; Chen C; Wu BL; Li EM; Fu JH; Ye S; Xie D
Clin Cancer Res; 2017 Jan; 23(1):298-310. PubMed ID: 27407092
[TBL] [Abstract][Full Text] [Related]
13. Tumor-derived exosomal hyaluronidase 1 induced M2 macrophage polarization and promoted esophageal cancer progression.
Yuan J; Hou B; Guo K; Zhu J; Xiao H
Exp Cell Res; 2024 Jun; 439(1):113963. PubMed ID: 38382806
[TBL] [Abstract][Full Text] [Related]
14. MiR-130b plays an oncogenic role by repressing PTEN expression in esophageal squamous cell carcinoma cells.
Yu T; Cao R; Li S; Fu M; Ren L; Chen W; Zhu H; Zhan Q; Shi R
BMC Cancer; 2015 Jan; 15():29. PubMed ID: 25637514
[TBL] [Abstract][Full Text] [Related]
15. Loss of miR-200b promotes invasion via activating the Kindlin-2/integrin β1/AKT pathway in esophageal squamous cell carcinoma: An E-cadherin-independent mechanism.
Zhang HF; Alshareef A; Wu C; Li S; Jiao JW; Cao HH; Lai R; Xu LY; Li EM
Oncotarget; 2015 Oct; 6(30):28949-60. PubMed ID: 26334393
[TBL] [Abstract][Full Text] [Related]
16. Periostin in Cancer-Associated Fibroblasts Promotes Esophageal Squamous Cell Carcinoma Progression by Enhancing Cancer and Stromal Cell Migration.
Miyako S; Koma YI; Nakanishi T; Tsukamoto S; Yamanaka K; Ishihara N; Azumi Y; Urakami S; Shimizu M; Kodama T; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
Am J Pathol; 2024 May; 194(5):828-848. PubMed ID: 38320632
[TBL] [Abstract][Full Text] [Related]
17. Dysregulated CC receptor/ligand in monocytes/macrophages from tongue squamous cell carcinoma patients is partially rectified by interferon α-2b.
Chakraborty K; Bose A; Goswami KK; Mukherjee KK; Goswami S; Ghosh D; Chakraborty T; Sarkar K; Pal S; Bhowmick A; Biswas J; Baral R
Hum Immunol; 2012 Jan; 73(1):38-47. PubMed ID: 22085486
[TBL] [Abstract][Full Text] [Related]
18. Focal adhesion kinase (FAK) inhibitor-defactinib suppresses the malignant progression of human esophageal squamous cell carcinoma (ESCC) cells via effective blockade of PI3K/AKT axis and downstream molecular network.
Zhang L; Zhao D; Wang Y; Zhang W; Zhang J; Fan J; Zhan Q; Chen J
Mol Carcinog; 2021 Feb; 60(2):113-124. PubMed ID: 33283357
[TBL] [Abstract][Full Text] [Related]
19. Tumor associated macrophage expressing CD204 is associated with tumor aggressiveness of esophageal squamous cell carcinoma.
Shigeoka M; Urakawa N; Nakamura T; Nishio M; Watajima T; Kuroda D; Komori T; Kakeji Y; Semba S; Yokozaki H
Cancer Sci; 2013 Aug; 104(8):1112-9. PubMed ID: 23648122
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant Chemotherapy Induces IL34 Signaling and Promotes Chemoresistance via Tumor-Associated Macrophage Polarization in Esophageal Squamous Cell Carcinoma.
Nakajima S; Mimura K; Saito K; Thar Min AK; Endo E; Yamada L; Kase K; Yamauchi N; Matsumoto T; Nakano H; Kanke Y; Okayama H; Saito M; Neupane P; Saze Z; Watanabe Y; Hanayama H; Hayase S; Kaneta A; Momma T; Ohki S; Ohira H; Kono K
Mol Cancer Res; 2021 Jun; 19(6):1085-1095. PubMed ID: 33674443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
